Anthony J. Avery

Anthony J. Avery

Auto-generated profile, based on publicly available information

Anthony J. Avery

Centre for Academic Primary Care, School of Medicine, University of Nottingham, Nottingham, UK

Research Focus & Metrics

Academic Career Length

48Years (1979-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2011 in BMC Medical Research Methodology
Verified
Journal Article
Open access
PDF file
SCSarah Crowe
Sarah Crowe
KCKathrin Cresswell
Kathrin Cresswell
ARAnn Robertson
Ann Robertson
GHGuro Huby
Guro Huby
AAAnthony Avery
Anthony Avery
ASAziz Sheikh
Aziz Sheikh
The case study approach allows in-depth, multi-faceted explorations of complex issues in their real-life settings. The value of the case study approach is well recognised in the fields of business, law and policy, but somewhat less so in health services research. Based on our experiences of conducting several health-related case studies, we reflect on the different types of case study design, the specific research questions this approach can help answer, the data sources that tend to be used, and the particular advantages and disadvantages of employing this methodological approach. The paper concludes with key pointers to aid those designing and appraising proposals for conducting case study research, and a checklist to help readers assess the quality of case study reports.

1 January 2007 in Journal of the American Medical Informatics Association
Verified
Journal Article
Open access
PDF file
GKGilad J. Kuperman
Gilad J. Kuperman
ABA. Bobb
A. Bobb
TPThomas H. Payne
Thomas H. Payne
AAA. J. Avery
A. J. Avery
TGTejal K. Gandhi
Tejal K. Gandhi
DBD. W. Bates
D. W. Bates
While medications can improve patients' health, the process of prescribing them is complex and error prone, and medication errors cause many preventa

26 June 2006 in British Journal of Clinical Pharmacology
Verified
Journal Article
Open access
PDF file
RHR. L. Howard
R. L. Howard
AAA. J. Avery
A. J. Avery
SSS. Slavenburg
S. Slavenburg
SRS. Royal
S. Royal
GPG. Pipe
G. Pipe
MPMunir Pirmohamed
Munir Pirmohamed
Aims: Previous systematic reviews have found that drug‐related morbidity accounts for 4.3% of preventable hospital admissions. None, however, has identified the drugs most commonly responsible for preventable hospital admissions. The aims of this study were to estimate the percentage of preventable drug‐related hospital admissions, the most common drug causes of preventable hospital admissions and the most common underlying causes of preventable drug‐related admissions.Methods: Bibliographic databases and reference lists from eligible articles and study authors were the sources for data. Seventeen prospective observational studies reporting the proportion of preventable drug‐related hospital admissions, causative drugs and/or the underlying causes of hospital admissions were selected. Included studies used multiple reviewers and/or explicit criteria to assess causality and preventability of hospital admissions. Two investigators abstracted data from all included studies using a purpose‐made data extraction form.Results: From 13 papers the median percentage of preventable drug‐related admissions to hospital was 3.7% (range 1.4–15.4). From nine papers the majority (51%) of preventable drug‐related admissions involved either antiplatelets (16%), diuretics (16%), nonsteroidal anti‐inflammatory drugs (11%) or anticoagulants (8%). From five studies the median proportion of preventable drug‐related admissions associated with prescribing problems was 30.6% (range 11.1–41.8), with adherence problems 33.3% (range 20.9–41.7) and with monitoring problems 22.2% (range 0–31.3).Conclusions: Four groups of drugs account for more than 50% of the drug groups associated with preventable drug‐related hospital admissions. Concentrating interventions on these drug groups could reduce appreciably the number of preventable drug‐related admissions to hospital from primary care.

1 April 2012 in The Lancet
Verified
Journal Article
Open access
AAAnthony J Avery
Anthony J Avery
SRSarah Rodgers
Sarah Rodgers
JCJudith A Cantrill
Judith A Cantrill
SASarah Armstrong
Sarah Armstrong
KCKathrin Cresswell
Kathrin Cresswell
ASAziz Sheikh
Aziz Sheikh
Medication errors are common in primary care and are associated with considerable risk of patient harm. We tested whether a pharmacist-led, information technology-based intervention was more effective than simple feedback in reducing the number of patients at risk of measures related to hazardous prescribing and inadequate blood-test monitoring of medicines 6 months after the intervention. In this pragmatic, cluster randomised trial general practices in the UK were stratified by research site and list size, and randomly assigned by a web-based randomisation service in block sizes of two or four to one of two groups. The practices were allocated to either computer-generated simple feedback for at-risk patients (control) or a pharmacist-led information technology intervention (PINCER), composed of feedback, educational outreach, and dedicated support. The allocation was masked to researchers and statisticians involved in processing and analysing the data. The allocation was not masked to general practices, pharmacists, patients, or researchers who visited practices to extract data. [corrected]. Primary outcomes were the proportions of patients at 6 months after the intervention who had had any of three clinically important errors: non-selective non-steroidal anti-inflammatory drugs (NSAIDs) prescribed to those with a history of peptic ulcer without co-prescription of a proton-pump inhibitor; β blockers prescribed to those with a history of asthma; long-term prescription of angiotensin converting enzyme (ACE) inhibitor or loop diuretics to those 75 years or older without assessment of urea and electrolytes in the preceding 15 months. The cost per error avoided was estimated by incremental cost-effectiveness analysis. This study is registered with Controlled-Trials.com, number ISRCTN21785299. 72 general practices with a combined list size of 480,942 patients were randomised. At 6 months' follow-up, patients in the PINCER group were significantly less likely to have been prescribed a non-selective NSAID if they had a history of peptic ulcer without gastroprotection (OR 0·58, 95% CI 0·38-0·89); a β blocker if they had asthma (0·73, 0·58-0·91); or an ACE inhibitor or loop diuretic without appropriate monitoring (0·51, 0·34-0·78). PINCER has a 95% probability of being cost effective if the decision-maker's ceiling willingness to pay reaches £75 per error avoided at 6 months. The PINCER intervention is an effective method for reducing a range of medication errors in general practices with computerised clinical records. Patient Safety Research Portfolio, Department of Health, England.

17 October 2011 in BMJ
Verified
Journal Article
Open access
PDF file
ASAziz Sheikh
Aziz Sheikh
TCTony Cornford
Tony Cornford
NBNicholas Barber
Nicholas Barber
AAAnthony Avery
Anthony Avery
ATAmirhossein Takian
Amirhossein Takian
KCKathrin Cresswell
Kathrin Cresswell
Objectives To evaluate the implementation and adoption of the NHS detailed care records service in “early adopter” hospitals in England. Design Theoretically informed, longitudinal qualitative evaluation based on case studies. Setting 12 “early adopter” NHS acute hospitals and specialist care settings studied over two and a half years. Data sources Data were collected through in depth interviews, observations, and relevant documents relating directly to case study sites and to wider national developments that were perceived to impact on the implementation strategy. Data were thematically analysed, initially within and then across cases. The dataset consisted of 431 semistructured interviews with key stakeholders, including hospital staff, developers, and governmental stakeholders; 590 hours of observations of strategic meetings and use of the software in context; 334 sets of notes from observations, researchers’ field notes, and notes from national conferences; 809 NHS documents; and 58 regional and national documents. Results Implementation has proceeded more slowly, with a narrower scope and substantially less clinical functionality than was originally planned. The national strategy had considerable local consequences (summarised under five key themes), and wider national developments impacted heavily on implementation and adoption. More specifically, delays related to unrealistic expectations about the capabilities of systems; the time needed to build, configure, and customise the software; the work needed to ensure that systems were supporting provision of care; and the needs of end users for training and support. Other factors hampering progress included the changing milieu of NHS policy and priorities; repeatedly renegotiated national contracts; different stages of development of diverse NHS care records service systems; and a complex communication process between different stakeholders, along with contractual arrangements that largely excluded NHS providers. There was early evidence that deploying systems resulted in important learning within and between organisations and the development of relevant competencies within NHS hospitals. Conclusions Implementation of the NHS Care Records Service in “early adopter” sites proved time consuming and challenging, with as yet limited discernible benefits for clinicians and no clear advantages for patients. Although our results might not be directly transferable to later adopting sites because the functionalities we evaluated were new and untried in the English context, they shed light on the processes involved in implementing major new systems. The move to increased local decision making that we advocated based on our interim analysis has been pursued and welcomed by the NHS, but it is important that policymakers do not lose sight of the overall goal of an integrated interoperable solution.

9 May 2006 in International Journal of Obesity
Verified
Journal Article
Open access
PDF file
TST H Sach
T H Sach
GBG R Barton
G R Barton
MDMichael Doherty
Michael Doherty
KMK R Muir
K R Muir
CJC Jenkinson
C Jenkinson
AAA J Avery
A J Avery
Background: No other studies have compared the relationship between body mass index (BMI) and health-related quality of life (HRQL) on more than one utility measure. Estimating the HRQL effects of obesity on a (common) utility scale enables the relative cost-effectiveness of interventions designed to alleviate obesity to be estimated. Objective: To examine the relationship between BMI and HRQL according to the EQ-5D, EuroQol visual analogue scale (EQ-VAS) and SF-6D. Methods: Patients aged ⩾45 years at one UK general practice were asked to complete the EQ-5D, EQ-VAS, SF-36 questionnaire (used to derive the SF-6D), and information on their characteristics and co-morbidity. Body mass index was categorized according to the World Health Organization (WHO) recommendations. Regression analysis was used to compare the HRQL of normal BMI patients to the HRQL of patients in other BMI categories, while controlling for patient characteristics and co-morbidity. Results: A total of 1865 patients responded (67%), mean BMI 26.0 kg/m2, 16% obese (BMI⩾30). Patients with back pain, hip pain, knee pain, asthma, diabetes or osteoarthritis were also significantly more likely to be obese. After controlling for other factors, compared to normal BMI patients, obese patients had a lower HRQL according to the EQ-5D (P<0.01), EQ-VAS (P<0.001) and SF-6D (P<0.001). Pre-obese patients were not estimated to have a significantly lower HRQL, and underweight patients were only estimated to have a significantly lower HRQL according to the SF-6D. These results arose because, on the EQ-5D, obese patients were found to have significantly more problems with mobility and pain, compared to physical functioning, social functioning and role limitations on the SF-6D. Whereas, according to the SF-6D, underweight patients had significantly more problems on the dimension of role limitation. Conclusion: The EQ-5D, EQ-VAS and SF-6D were in agreement that, relative to a normal BMI, obesity is associated with a lower HRQL, even after controlling for patient characteristics and co-morbidity. These three measures are thereby sensitive to the HRQL effects of obesity and can be used to estimate the cost-effectiveness of interventions designed to alleviate obesity.